Alterome Therapeutics Appoints Leo Faoro, MD, MBA, as Chief Medical Officer

Veteran medical oncologist with a proven track record of advancing cancer therapies from early trials through regulatory approval to lead ongoing clinical development of ALTA2618 and ALTA3263